| 000 | 00660nam a22002417a 4500 | ||
|---|---|---|---|
| 008 | 160406b xxu||||| |||| 00| 0 eng d | ||
| 040 | _cVAD | ||
| 041 | _aNederlands | ||
| 100 | _aVan Amsterdam, J.G.C | ||
| 245 | _aDesigner drugs in Europa [PDF] | ||
| 260 |
_aBilthoven _bRIVM _c2013 |
||
| 300 | _a51 p. | ||
| 650 | _adrugs | ||
| 650 | _aNieuwe Psychoactieve Stoffen | ||
| 650 | _aEuropese Unie | ||
| 650 | _aonderzoeksrapporten | ||
| 650 | _aproductinformatie | ||
| 650 | _amephedrone | ||
| 650 | _aepidemiologie | ||
| 700 | _aKorf, D.J. | ||
| 700 | _aNabben, A.L.W.M. | ||
| 856 | _uhttp://www.google.com/search?q=designer-drugs-in-europa rivm | ||
| 999 |
_c18341 _d18341 |
||